[Immunoscintigraphy in oncology exemplified by ovarian cancer].
Diagnostic and therapeutical work increasingly uses immunologic and nuclear medical methods, which is especially true in oncology. Recently tumor localization has gained much from immunoscintigraphy, a noninvasive method combining immunologic and nuclear medicine techniques. After application and accumulation of radiolabelled tumor-associated monoclonal antibodies, it is possible to obtain malignant tumor sites by scintigraphy. In the following a short introduction of the method and its use in ovarian cancer patients is presented.